高级检索
当前位置: 首页 > 详情页

Klotho protects against LPS-induced inflammation injury by inhibiting Wnt and NF-κB pathways in HK-2 cells

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Tongji Hosp, Dept Pediat, Tongji Med Coll, Wuhan, Peoples R China
出处:
ISSN:

摘要:
Aim: This study aimed to investigate the effect and mechanism of Klotho in lipopolysaccharide (LPS)-induced inflammation injury in HK-2 cells. Methods: We established LPS-induced inflammation injury model in HK-2 cells. The LPS-induced HK-2 cells were transfected with pc-Klotho, pcDNA3.1, siKlotho or siNC. Cell viability, apoptosis and reactive oxygen species (ROS) level were detected by MIT assay, Annexin V-FITC/PI Apoptosis Detection kit and 2,7-dichlorofluorescein diacetate, respectively. The levels of inflammatory factors and the expressions of proteins related to Wnt and nuclear factor-KB (NF-KB) signaling pathway were detected by RT-qPCR and western blotting, respectively. Results: Compared with cells transfected with pcDNA 3.1, cell viability was remarkably increased and cell apoptosis rate was decreased in LPS-induced cells with pc-Klotho (p < 0.05). Conversely, LPS-induced cells with siKlotho showed lower cell viability and higher cell apoptosis rate than cells with siNC (p < 0.05). The levels of ROS, tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) was significantly reduced in LPS-induced cells with pc-Klotho compared with cells with pcDNA3.1 (p < 0.05). Consistently, LPS-induced cells with siKlotho showed increased levels of ROS, TNF-a and IL-6 compared with cells with siNC (p < 0.05). Wnt signaling pathway related protein Wnt3a and NF-KB signaling pathway related to proteins p-IKBa were significantly down-regulated in LPS-induced cells with pc-Klotho compared with cells with pcDNA3.1, while up-regulated in LPS-induced cells with pc-Klotho compared with cells with pcDNA3.1 (p < 0.05). Conclusions: Klotho may play an inhibiting role in LPS-induced inflammation injury by inhibiting NF-KB and Wnt signaling pathways in HK-2 cells.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 药物化学 4 区 化学综合 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 药物化学 4 区 化学:综合 4 区 药学
JCR分区:
出版当年[2015]版:
Q3 CHEMISTRY, MULTIDISCIPLINARY Q4 PHARMACOLOGY & PHARMACY Q4 CHEMISTRY, MEDICINAL
最新[2023]版:
Q3 CHEMISTRY, MULTIDISCIPLINARY Q3 PHARMACOLOGY & PHARMACY Q4 CHEMISTRY, MEDICINAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者单位: [1]Tongji Hosp, Dept Pediat, Tongji Med Coll, Wuhan, Peoples R China
通讯作者:
通讯机构: [1]Tongji Hosp, Dept Pediat, Tongji Med Coll, Wuhan, Peoples R China [*1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pediat, 1095,Jiefang Ave, Wuhan 430030, Hubei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:432 今日访问量:0 总访问量:414 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)